1146 related articles for article (PubMed ID: 16410796)
21. Toll-like receptors' two-edged sword: when immunity meets apoptosis.
Salaun B; Romero P; Lebecque S
Eur J Immunol; 2007 Dec; 37(12):3311-8. PubMed ID: 18034428
[TBL] [Abstract][Full Text] [Related]
22. Dissecting negative regulation of Toll-like receptor signaling.
Kondo T; Kawai T; Akira S
Trends Immunol; 2012 Sep; 33(9):449-58. PubMed ID: 22721918
[TBL] [Abstract][Full Text] [Related]
23. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors.
Horng T; Barton GM; Flavell RA; Medzhitov R
Nature; 2002 Nov; 420(6913):329-33. PubMed ID: 12447442
[TBL] [Abstract][Full Text] [Related]
24. Signaling pathways downstream of pattern-recognition receptors and their cross talk.
Lee MS; Kim YJ
Annu Rev Biochem; 2007; 76():447-80. PubMed ID: 17328678
[TBL] [Abstract][Full Text] [Related]
25. Regulation of innate immune responses by Toll-like receptors.
Takeda K; Akira S
Jpn J Infect Dis; 2001 Dec; 54(6):209-19. PubMed ID: 11862002
[TBL] [Abstract][Full Text] [Related]
26. Suppressive effects of dehydrocostus lactone on the toll-like receptor signaling pathways.
Kim SY; Heo S; Kim SH; Kwon M; Sung NJ; Ryu AR; Lee MY; Park SA; Youn HS
Int Immunopharmacol; 2020 Jan; 78():106075. PubMed ID: 31812722
[TBL] [Abstract][Full Text] [Related]
27. Toll-like receptor downstream signaling.
Kawai T; Akira S
Arthritis Res Ther; 2005; 7(1):12-9. PubMed ID: 15642149
[TBL] [Abstract][Full Text] [Related]
28. The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors.
Hara H; Ishihara C; Takeuchi A; Imanishi T; Xue L; Morris SW; Inui M; Takai T; Shibuya A; Saijo S; Iwakura Y; Ohno N; Koseki H; Yoshida H; Penninger JM; Saito T
Nat Immunol; 2007 Jun; 8(6):619-29. PubMed ID: 17486093
[TBL] [Abstract][Full Text] [Related]
29. Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta.
Jiang Z; Mak TW; Sen G; Li X
Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3533-8. PubMed ID: 14982987
[TBL] [Abstract][Full Text] [Related]
30. Role of Toll-like receptor responses for sepsis pathogenesis.
Weighardt H; Holzmann B
Immunobiology; 2007; 212(9-10):715-22. PubMed ID: 18086373
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction.
Uematsu S; Sato S; Yamamoto M; Hirotani T; Kato H; Takeshita F; Matsuda M; Coban C; Ishii KJ; Kawai T; Takeuchi O; Akira S
J Exp Med; 2005 Mar; 201(6):915-23. PubMed ID: 15767370
[TBL] [Abstract][Full Text] [Related]
32. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6.
Häcker H; Redecke V; Blagoev B; Kratchmarova I; Hsu LC; Wang GG; Kamps MP; Raz E; Wagner H; Häcker G; Mann M; Karin M
Nature; 2006 Jan; 439(7073):204-7. PubMed ID: 16306937
[TBL] [Abstract][Full Text] [Related]
33. Cactin targets the MHC class III protein IkappaB-like (IkappaBL) and inhibits NF-kappaB and interferon-regulatory factor signaling pathways.
Atzei P; Gargan S; Curran N; Moynagh PN
J Biol Chem; 2010 Nov; 285(47):36804-17. PubMed ID: 20829348
[TBL] [Abstract][Full Text] [Related]
34. MAVS-dependent IRF3/7 bypass of interferon β-induction restricts the response to measles infection in CD150Tg mouse bone marrow-derived dendritic cells.
Takaki H; Honda K; Atarashi K; Kobayashi F; Ebihara T; Oshiumi H; Matsumoto M; Shingai M; Seya T
Mol Immunol; 2014 Feb; 57(2):100-10. PubMed ID: 24096085
[TBL] [Abstract][Full Text] [Related]
35. Toll-like receptor signaling pathways.
Barton GM; Medzhitov R
Science; 2003 Jun; 300(5625):1524-5. PubMed ID: 12791976
[TBL] [Abstract][Full Text] [Related]
36. Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy.
Li TT; Ogino S; Qian ZR
World J Gastroenterol; 2014 Dec; 20(47):17699-708. PubMed ID: 25548469
[TBL] [Abstract][Full Text] [Related]
37. Toll-like receptor signaling and regulation of cytokine gene expression in the immune system.
Ozato K; Tsujimura H; Tamura T
Biotechniques; 2002 Oct; Suppl():66-8, 70, 72 passim. PubMed ID: 12395929
[TBL] [Abstract][Full Text] [Related]
38. Suppression of TRIF-dependent signaling pathway of toll-like receptors by (E)-1-(2-(2-nitrovinyl)phenyl)pyrrolidine.
Gu GJ; Eom SH; Suh CW; Koh KO; Kim DY; Youn HS
Eur J Pharmacol; 2013 Dec; 721(1-3):109-15. PubMed ID: 24080550
[TBL] [Abstract][Full Text] [Related]
39. Suppression of MyD88- and TRIF-dependent signaling pathways of Toll-like receptor by (-)-epigallocatechin-3-gallate, a polyphenol component of green tea.
Youn HS; Lee JY; Saitoh SI; Miyake K; Kang KW; Choi YJ; Hwang DH
Biochem Pharmacol; 2006 Sep; 72(7):850-9. PubMed ID: 16890209
[TBL] [Abstract][Full Text] [Related]
40. Myeloid differentiation factor 88-dependent and -independent pathways in toll-like receptor signaling.
Akira S; Hoshino K
J Infect Dis; 2003 Jun; 187 Suppl 2():S356-63. PubMed ID: 12792852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
